Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America

Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America

PURPOSEMultiple myeloma (MM) is a highly heterogeneous, incurable disease most frequently diagnosed in the elderly. Therefore, data on clinical characteristics and outcomes in the very young population are scarce.PATIENTS AND METHODSWe analyzed clinical characteristics, response to treatment, and su...

Full description

Bibliographic Details
Main Authors: Humberto Martínez-Cordero, Camila Peña, Natalia Paola Schutz, Virginia Bove, Fiorella Villano, Cecilia Beltran, Javiera Donoso, Hernán López-Vidal, Macarena Alejandra Roa Salinas, Pablo Soto, Paola Ochoa, Patricio Duarte, Guillermina Remaggi, Ariel Corzo, Claudia Shanley, Sergio Lopresti, Sergio Orlando, Verónica Verri, Luis Darío Quiroga, Dorotea Fantl, Jhoanna Ramirez, Alejandro Ospina-Idárraga, Henry Idrobo, Guillermo Quintero, Rigoberto Gomez, Omar Cantú-Martínez, David Gomez-Almaguer, Guillermo J. Ruiz-Arguelles, Kenny Mauricio Galvez-Cárdenas, Luis Antonio Salazar, Isabella Novoa-Caicedo, María Cynthia Fuentes-Lacouture, Paola Spirko, María Isabel Arbeláez, Mario Pereira, Jaime Valdes, Jule Vasquez, Alana von Glasenapp, Eloísa Riva
Format: Article
Language:English
Published: American Society of Clinical Oncology 2023-09-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.23.00182

Internet

https://ascopubs.org/doi/10.1200/GO.23.00182

Similar Items